Its biofermentation manufacturing process guarantees a purity above 99.9%, without any animal-derived material
The current Retatrutide availability is strictly limited to participants in authorized clinical trials, as it has not yet received regulatory approval from the FDA
September 1st, 2024: Ozempic lawsuits surge from 346 to 869 cases amid growing gastroparesis concerns The number of Ozempic lawsuits has grown significantly, increasing from 346 in August to 869 in September
As of Summer 2023, Wegovy (semaglutide) and Saxenda (liraglutide) are approved for weight loss
Yet, these are the very populations now being considered for treatment
helps regulate appetite and mood (key factors in overeating), and is a great treatment for people who cannot absorb vitamin B12